
|Articles|April 1, 2002
Mohs better suited to remove sebaceous carcinoma of eyelid
New York - With postexcision recurrence rates of 30 percent , Mohs surgery might be the better alternative in the treatment of sebaceous gland carcinoma, according to James M. Spencer, M.D.)
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Transformative Advances This Year and Beyond
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
5


















